Walter R. Maupay
Vorsitzender bei DSM Biomedical, Inc.
Profil
Walter R.
Maupay is currently the Chairman at DSM Biomedical, Inc. He previously held positions as Chairman & President at Calgon Vestal Laboratories, Inc., Director at SyntheMed, Inc., Director at PolyMedica Corp., and Director at Cubist Pharmaceuticals LLC.
He also served as Group Executive at Bristol Myers Squibb Co. and Divisional President at Merck & Co., Inc. Mr. Maupay holds an MBA from Lehigh University and an undergraduate degree from Temple University (Pennsylvania).
Aktive Positionen von Walter R. Maupay
Unternehmen | Position | Beginn |
---|---|---|
DSM Biomedical, Inc.
DSM Biomedical, Inc. Medical SpecialtiesHealth Technology DSM Biomedical, Inc. manufactures and designs medical device materials. The firm's products include bioceramics, polyurethanes, device development, hydrophilic coating solutions, polyethylenes, collagen, and extracellular matrix and drug delivery materials. The company was founded by Kenneth R. Kensey and John E. Nash in 1984 and is headquartered in Exton, PA. | Vorsitzender | 01.06.1995 |
Ehemalige bekannte Positionen von Walter R. Maupay
Unternehmen | Position | Ende |
---|---|---|
SyntheMed, Inc.
SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | Direktor/Vorstandsmitglied | 16.09.2011 |
CUBIST PHARMACEUTICALS INC | Direktor/Vorstandsmitglied | 01.01.2010 |
PolyMedica Corp.
PolyMedica Corp. Specialty StoresRetail Trade PolyMedica Corp. develops and sells healthcare products and related services primarily to seniors. The firm offers blood glucose testing supplies and related services to diabetics. The company was founded in 1988 and is headquartered in Port St. Lucie, FL. | Direktor/Vorstandsmitglied | 31.10.2007 |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.01.1995 |
Calgon Vestal Laboratories, Inc.
Calgon Vestal Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Part of STERIS Plc (Ireland), Calgon Vestal Laboratories, Inc. is a company that specializes in skin care and infection control products. The company is based in New York, NY. Calgon Vestal Laboratories was acquired by Bristol Myers Squibb Co. from Merck & Co., Inc. on January 15, 1995 for $261.50 million. | Vorsitzender | 01.12.1994 |
Ausbildung von Walter R. Maupay
Temple University (Pennsylvania) | Undergraduate Degree |
Lehigh University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
MERCK & CO., INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
SyntheMed, Inc.
SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | Health Technology |
PolyMedica Corp.
PolyMedica Corp. Specialty StoresRetail Trade PolyMedica Corp. develops and sells healthcare products and related services primarily to seniors. The firm offers blood glucose testing supplies and related services to diabetics. The company was founded in 1988 and is headquartered in Port St. Lucie, FL. | Retail Trade |
DSM Biomedical, Inc.
DSM Biomedical, Inc. Medical SpecialtiesHealth Technology DSM Biomedical, Inc. manufactures and designs medical device materials. The firm's products include bioceramics, polyurethanes, device development, hydrophilic coating solutions, polyethylenes, collagen, and extracellular matrix and drug delivery materials. The company was founded by Kenneth R. Kensey and John E. Nash in 1984 and is headquartered in Exton, PA. | Health Technology |
Cubist Pharmaceuticals LLC
Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
Calgon Vestal Laboratories, Inc.
Calgon Vestal Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Part of STERIS Plc (Ireland), Calgon Vestal Laboratories, Inc. is a company that specializes in skin care and infection control products. The company is based in New York, NY. Calgon Vestal Laboratories was acquired by Bristol Myers Squibb Co. from Merck & Co., Inc. on January 15, 1995 for $261.50 million. | Health Technology |